🔎 Trials Near Me

Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Nebraska › Omaha

Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Omaha, NE

7 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Omaha (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #2, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
  • Nebraska Medicine-Bellevue, Bellevue · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Ap rekriteFaz 1
  • Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Ap rekriteFaz 1/2
  • Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Ap rekriteFaz 3
  • Research Site, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07720284

Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)

Ap rekriteEtid obsèvasyon
  • University of Nebraska Medical Center, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Oct 31, 2025 · NCT06396533

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Omaha
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil

Lòt etid nan Omaha

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.